Who owns NEUBASE THERAPEUTICS INC?
- Ticker: NBSE
- CUSIP Number: 64132k201
Tip: Access positions for across all investors
Analyze quarterly positions in Neubase Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Neubase Therapeutics stock
Who bought or sold NEUBASE THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
DME Capital Management | 136k | $61k | 100% | Mar 2024 |
|
Greenlight Capital | 136k | $101k | 0% | Dec 2023 |
|
Point72 Asset Management | 63k | $28k | 0% | Mar 2024 |
|
Carnegie Mellon University | 47k | $21k | 0% | Mar 2024 |
|
Vanguard Group | 19k | $8.5k | 0% | Mar 2024 |
|
Kestra Advisory Services | 17k | $12k | -8% | Dec 2023 |
|
Springbok Capital Management | 16k | $7.0k | 0% | Mar 2024 |
|
Geode Capital Management | 16k | $6.8k | 0% | Mar 2024 |
|
UBS Group | 4.1k | $1.8k | -94% | Mar 2024 |
|
Tower Research Capital | 2.6k | $1.2k | 6% | Mar 2024 |
|
Cubist Systematic Strategies | 1.3k | $562.950000 | 100% | Mar 2024 |
|
Bank of America Corporation | 804.00 | $371.046000 | 0% | Mar 2024 |
|
First Manhattan | 353.00 | $158.002800 | -50% | Mar 2024 |
|
Royal Bank of Canada | 153.00 | $0 | -49% | Mar 2024 |
|
Wells Fargo & Company | 79.00 | $34.760000 | 0% | Mar 2024 |
|
Advisor Group Holdings | 22.00 | $9.999000 | 0% | Mar 2024 |
|
Pnc Financial Services | 21.00 | $9.000600 | 0% | Mar 2024 |
|
Newbridge Financial Services Group | 12.00 | $5.000400 | 0% | Mar 2024 |
|
Morgan Stanley | 9.00 | $4.500000 | 0% | Mar 2024 |
|
Who sold out of Neubase Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Two Sigma Investments | Dec 2023 | 21k | $16k |
BlackRock | Sep 2023 | 440.00 | $383.152000 |
Global Wealth Management Investment Advisory | Dec 2023 | 12.00 | $9.000000 |